United States: The FDA Gets Social: Interpreting Its Draft Social Media Guidance

Last Updated: January 28 2014
Article by Sharon Klein and Melissa L. Nuñez

The U.S. Food and Drug Administration (FDA) recently released draft guidance that paves the way for regulated companies to harness the power of social media.1 This draft guidance addresses how FDA-regulated manufacturers, packers and distributors of prescription human and animal drugs and biologics ("regulated firms") can comply with regulatory requirements for postmarketing submissions of interactive promotional materials. Regulated firms have been shut out of real-time communications via social networking sites due to restrictions on promotional activities. The new guidance, while not yet finalized, indicates that regulated firms may jump into this market in the coming months. The FDA has requested comments on the draft guidance by April 14, 2014.

Background

Generally, regulated firms are required to submit all promotional labeling and advertising materials to the FDA at the time of their initial dissemination or publication. In the case of real-time social media (think: blogs, Facebook updates, tweets, podcasts and online communities), submission at the time of initial dissemination would be all but impossible. Now, the FDA has issued guidance for submission of most materials after-the-fact.

What Is 'Interactive Promotional Media'?

"Interactive promotional media" is the term the FDA is using to refer to real-time social media promotions by regulated firms. The key guidance relating to determining whether a regulated firm is responsible for interactive promotional media is as follows:

1. Regulated firms are responsible for promotional communications on sites that are owned, controlled, created, influenced or operated by or on behalf of the firm.

What This Means: Promotional content posted to company-sponsored sites is clearly covered and must be submitted to the FDA. The trickier issue is whether a regulated firm influences or has control over a site owned by a third party. The FDA's threshold is very low; the FDA states that a firm is responsible for promotion on a third-party site if it has "any control or influence" (emphasis added) on the third-party site. Indeed, the influence can be limited in scope and still trigger responsibility; editorial, preview or review privileges will suffice. Notably, financial support alone does not trigger responsibility, so long as it is not coupled with other influence.

If a regulated firm does not have influence over a third-party site, it need only submit to the FDA the promotional content it provided that site but not everything on the third-party site. If a regulated firm does have such influence, it will be responsible for submitting the promotion, along with the surrounding pages, to the FDA and otherwise meet the new postmarketing submission requirements.

Pepper Point: To reduce submission burdens to the FDA, regulated firms should not request previews of third-party Web sites or direct the particular placement of promotional materials on third-party Web sites.

2. Regulated firms may be responsible for content on third-party sites if it is generated by their employees or agents or if the regulated firm has control over or influence on the site.

What This Means: Comments by employees and other agents acting on a regulated firm's behalf and made on third-party Web sites about the regulated firm's products are attributed to the regulated firm for purposes of FDA submission. For example, if a paid speaker makes a comment on a third-party site, that material should be submitted to the FDA.

Pepper Point: Regulated firms should consider training employees so they understand the possible consequences of their online activity when acting on behalf of the regulated firm. Additionally, regulated firms should take steps to distance themselves from online content not under their control.

3. Regulated firms are responsible for content generated by employees and agents acting on their behalf to promote the regulated firm's products.

What This Means: Content placed online by employees and agents that promotes a regulated firm's products must be submitted to the FDA pursuant to the new postmarketing guidance. The FDA has also recommended that regulated firms clearly identify content generated by such employees and agents. Notably, the FDA will not "ordinarily" hold regulated firms responsible for user-generated content on firm-owned or controlled venues as long as the user has no affiliation with the regulated firm and the regulated firm had no influence on the user-generated content.

Pepper Point: Regulated firms should strictly police the content its employees and agents put on the Internet on their behalf and consider including a unique identifier, such as a logo, to clearly identify sponsored content. Consider including a pre-approval requirement for social media advertising in all contracts with advertisers.

Submission of 'Interactive Promotional Media' to the FDA

1. Regulated firms must submit sponsored sites to the FDA at the time of initial display.

What This Means: If a regulated firm creates or sponsors a Web site that will include interactive promotional media, it must submit a comprehensive static product Web site with the real-time or interactive components to the FDA at the time of initial display. The submission will include information that will allow the FDA to review the content and features of the site. Any changes to the site must be resubmitted to the FDA.

Pepper Point: Regulated firms should limit changes to Web sites or make multiple changes at one time to limit resubmissions to the FDA.

2. Regulated firms must submit the home page, the interactive or real-time communications and the regulated firm's first communication for any third-party sites that contain regulated interactive promotional media.

What This Means: If a regulated firm's participation in a third-party site is limited to interactive or real-time communications, it must submit to the FDA: (1) the homepage of the third-party site, (2) the interactive page(s) of the site, and (3) the regulated firm's first communication. The submission process for continued participation of regulated firms on such sites is streamlined in the case of "unrestricted" sites (sites that are publicly viewable and do not require a password or subscription).

3. Regulated firms must submit monthly updates to the FDA for all non-restricted sites.

What This Means: Regulated firms must make a monthly filing with the FDA to disclose all non-restricted sites that contain interactive or real-time communications. The filing will include, for each site: (1) the name, (2) URL, (3) date range, and (4) a cross-reference to the date of the most recent submission of the site. Notification is also required when a regulated firm ceases activity on a site.

Pepper Point: The FDA is allowing one filing per month for all sponsored sites, rather than a filing for each such site, which cuts down on paperwork.

4. Regulated firms must submit more detailed information for restricted sites.

What This Means: If sites with interactive promotional material are restricted (i.e., require a password or subscription) and are therefore not easily monitored by the FDA, regulated firms must submit more detailed information in their monthly filings. This includes all content related to the discussion, which may include independent user-generated content, to adequately provide context to facilitate the FDA's review. Screenshots and other visual representations of the actual site, including the real-time communications, must also be submitted. Additionally, the FDA has recommended that regulated firms take formatting factors into account when submitting materials in order to facilitate the FDA's review. Such factors include appearance, layout and visual impression.

Pepper Point: Regulated firms should take the greater disclosure burden into account in determining whether to utilize restricted sites for promotional materials.

Footnote

1. "Guidance for Industry: Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics" can be found at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM381352.pdf.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Melissa L. Nuñez
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Emails

From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.